Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Eton Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −9 vs. Q2 2021
- Shares held
- 5.96M
- −878.8K (−12.8%) vs. Q2 2021
- Total value
- $29.5M
- −$18.6M (−38.6%) vs. Q2 2021
- New holders
- 8
- 10 more added
- Sold out
- 17
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 3,088,100 | $15.6M | 2.91% | −604,500−16.4% | Reduced |
| Vanguard Group Inc | 866,465 | $4.37M | 0.00% | +4,925+0.6% | Added |
| AWM Investment Company, Inc. | 500,000 | $2.52M | 0.25% | 00.0% | Unchanged |
| BlackRock Inc. | 300,897 | $1.52M | 0.00% | −161−0.1% | Reduced |
| Geode Capital Management, LLC | 157,116 | $791.0K | 0.00% | +1,835+1.2% | Added |
| Susquehanna International Group, LLP | 117,493 | $592.0K | 0.00% | +117,493 | New |
| Bridgeway Capital Management, LLC | 100,500 | $507.0K | 0.01% | +25,500+34.0% | Added |
| State Street Corp | 83,772 | $422.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 82,314 | $415.0K | 0.04% | +24,917+43.4% | Added |
| Bank of New York Mellon Corp | 79,725 | $401.0K | 0.00% | +66,450+500.6% | Added |
| Citadel Advisors LLC | 63,146 | $318.0K | 0.00% | +5,271+9.1% | Added |
| Blair William & Co | 44,000 | $222.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 39,012 | $196.0K | 0.00% | −11,057−22.1% | Reduced |
| Morgan Stanley | 34,749 | $175.0K | 0.00% | +33,159+2,085.5% | Added |
| Bank of America Corp | 30,913 | $156.0K | 0.00% | +12,016+63.6% | Added |
| Susquehanna Fundamental Investments, LLC | 30,844 | $155.0K | 0.00% | +30,844 | New |
| Northern Trust Corp | 30,355 | $153.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 24,206 | $122.0K | 0.00% | −193,576−88.9% | Reduced |
| HighVista Strategies LLC | 21,517 | $109.0K | 0.07% | +10,884+102.4% | Added |
| Belvedere Trading LLC | 20,829 | $107.0K | 0.03% | +20,829 | New |
| Millennium Management LLC | 21,110 | $106.0K | 0.00% | −113,818−84.4% | Reduced |
| Goldman Sachs Group Inc | 20,446 | $103.0K | 0.00% | +20,446 | New |
| Two Sigma Investments, LP | 18,070 | $91.0K | 0.00% | +18,070 | New |
| Chicago Trust Co NA | 16,700 | $84.0K | 0.02% | +16,700 | New |
| XTX Topco Ltd | 14,652 | $74.0K | 0.02% | −40−0.3% | Reduced |
| Group One Trading, L.P. | 14,044 | $71.0K | 0.00% | +14,044 | New |
| MML Investors Services, LLC | 11,500 | $58.0K | 0.00% | 00.0% | Unchanged |
| Financial Advisors Network, Inc. | 10,633 | $53.0K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,236 | $32.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,382 | $22.0K | 0.00% | +4,382 | New |
| Barclays PLC | 2,137 | $11.0K | 0.00% | −1,853−46.4% | Reduced |
| Royal Bank of Canada | 1,000 | $5.00K | 0.00% | −2,113−67.9% | Reduced |
| Plante Moran Financial Advisors, LLC | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 765 | $3.86K | 0.00% | −868−53.2% | Reduced |
| Wells Fargo & Company | 123 | $1.00K | 0.00% | −316−72.0% | Reduced |
| Lindbrook Capital, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 105,300 | – | – | +3,500+3.4% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −84,912−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −78,542−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −51,800−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −50,500−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −36,079−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −18,691−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −18,320−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,837−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,363−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,072−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −810−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −243−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −229−100.0% | Sold out |